Suchergebnisse - "Im, S-A"

PubPharm (148)

1

Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer : Results From the Randomized, Phase II acelERA Breast Cancer Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Martín, M. | Lim, E. | Chavez-MacGregor, M. | +119

2

Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2- advanced breast cancer receiving first-line ribociclib plus fulvestrant

enthalten in: Breast cancer research : BCR | 2023

von Neven, P. | Fasching, P. | Chia, S. | +15

3

Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant

enthalten in: Breast cancer research | 2023

von Neven, P. | Fasching, P. | Chia, S. | +15

4

Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant

enthalten in: Breast cancer research | 2023

von Neven, P. | Fasching, P. | Chia, S. | +15

5

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer

enthalten in: ESMO open | 2023

von Im, S. | Gennari, A. | Park, Y. | +28

6

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Geyer, C. | Garber, J. | Gelber, R. | +174

7

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer : original article

enthalten in: Annals of oncology | 28 November 2022

von Geyer, C. | Garber, J. | Gelber, R. | +73

8

A first-in-human study of the anti-LAG-3 antibody favezelimab plus pembrolizumab in previously treated, advanced microsatellite stable colorectal cancer

enthalten in: ESMO open | 2022

von Garralda, E. | Sukari, A. | Lakhani, N. | +13

9

ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Gennari, A. | André, F. | Barrios, C. | +26

10

Potential role of CMPK1, SLC29A1, and TLE4 polymorphisms in gemcitabine-based chemotherapy in HER2-negative metastatic breast cancer patients : pharmacogenetic study results from the prospective randomized phase II study of eribulin plus gemcitabine versus paclitaxel plus gemcitabine (KCSG-BR-13-11)

enthalten in: ESMO open | 2021

von Cho, E. | Kim, J. | Im, S. | +11

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]